Insider · CIK 0001288452

BAY City Capital LLC

CIK 0001288452 Name as filed on the most recent filing

Filed as BAY City Capital LLC (34)

127 transaction lines · from 34 filings · filed 2007-04-30 to 2021-10-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

4 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-10-26 P, Open-market purchase Xilio Therapeutics, Inc.XLO 5,000,000, acquired Open Form 4 filing 0001104659-21-130027
2020-08-19 S, Open-market sale Madrigal Pharmaceuticals, Inc.MDGL 786,095, disposed Open Form 4 filing 0000899243-20-022972
2020-08-18 S, Open-market sale Madrigal Pharmaceuticals, Inc.MDGL 1,121,976, disposed Open Form 4 filing 0000899243-20-022972
2020-08-17 S, Open-market sale Madrigal Pharmaceuticals, Inc.MDGL 1,384,125, disposed Open Form 4 filing 0000899243-20-022972
2019-12-13 S, Open-market sale Madrigal Pharmaceuticals, Inc.MDGL 2 lines 126,564,000, disposed Open Form 4 filing 0000899243-19-029139
2018-06-25 P, Open-market purchase Kezar Life Sciences, Inc.KZR 2,250,000, acquired Open Form 4 filing 0001179110-18-009105
2018-06-11 S, Open-market sale Madrigal Pharmaceuticals, Inc.MDGL 2 lines 80,488,800, disposed Open Form 4 filing 0001179110-18-008424
2016-07-29 P, Open-market purchase Interleukin Genetics IncILIU 2 lines 3,000,000, acquired Open Form 4 filing 0000899243-16-026077
2016-01-12 P, Open-market purchase Epizyme, Inc.EPZM 2 lines 4,999,995, acquired Open Form 4 filing 0001209191-16-090962
2015-07-24 S, Open-market sale Sunesis Pharmaceuticals IncSNSS 4 lines 2,199,529, disposed Open Form 4 filing 0000899243-15-001801
2015-06-08 S, Open-market sale Nevro CorpNVRO 2 lines 23,578,570, disposed Open Form 4 filing 0001181431-15-008441
2014-12-23 P, Open-market purchase Interleukin Genetics IncILIU 2 lines 2,657,143, acquired Open Form 4 filing 0001209191-14-077958
2014-10-08 P, Open-market purchase Dermira, Inc.DERM 2 lines 1,105,792, acquired Open Form 4 filing 0001140361-14-037654
2014-08-28 S, Open-market sale Sunesis Pharmaceuticals IncSNSS 2 lines 1,577,020, disposed Open Form 4 filing 0001181431-14-030525
2014-08-27 S, Open-market sale Sunesis Pharmaceuticals IncSNSS 2 lines 822,014, disposed Open Form 4 filing 0001181431-14-030525
2014-08-26 S, Open-market sale Epizyme, Inc.EPZM 2 lines 7,027,800, disposed Open Form 4 filing 0001209191-14-054864
2014-08-25 S, Open-market sale Epizyme, Inc.EPZM 4 lines 7,027,803, disposed Open Form 4 filing 0001209191-14-054308
2014-08-22 S, Open-market sale Epizyme, Inc.EPZM 2 lines 4,154,765, disposed Open Form 4 filing 0001209191-14-054308
2014-08-21 S, Open-market sale Epizyme, Inc.EPZM 2 lines 1,277,339, disposed Open Form 4 filing 0001209191-14-054308
2014-08-12 S, Open-market sale Sunesis Pharmaceuticals IncSNSS 2 lines 251,230, disposed Open Form 4 filing 0001181431-14-029004
2014-08-11 S, Open-market sale Sunesis Pharmaceuticals IncSNSS 2 lines 218,103, disposed Open Form 4 filing 0001181431-14-029004
2014-08-08 S, Open-market sale Sunesis Pharmaceuticals IncSNSS 2 lines 4,468,568, disposed Open Form 4 filing 0001181431-14-029004
2014-02-10 S, Open-market sale Epizyme, Inc.EPZM 2 lines 13,650,010, disposed Open Form 4 filing 0001209191-14-009595
2013-06-05 P, Open-market purchase Epizyme, Inc.EPZM 2 lines 2,499,990, acquired Open Form 4 filing 0001209191-13-031138
2013-05-30 S, Open-market sale Hyperion Therapeutics IncHPTX 2 lines 112,686, disposed Open Form 4 filing 0001181431-13-031712
2013-05-28 S, Open-market sale Hyperion Therapeutics IncHPTX 248,238, disposed Open Form 4 filing 0001181431-13-031712

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
%, Ten percent owner
Ten percent owner
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 2
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. BAY CITY CAPITAL LLC, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001288452

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.